Newly discovered testosterone action may act on prostate cancer
A newly-discovered mode of action of testosterone is showing great promise in defining novel strategies for the development of drugs against prostate cancer.
Testosterone has been associated with a higher rate of certain cancers. Classically, testosterone passes through the cell membrane to act inside the cell. However recent work has indicated that testosterone may also act at the cell surface, through membrane androgen binding sites called Ambs.
Now a team lead by Professors Stournaras, Castanas and Gravanis at the Medical School of the University of Crete Heraklion, Greece, has discovered that activating these cell-surface testosterone binding sites can significantly reduce the size of prostate cancer tumours in animal models.
When testosterone is bound to another protein such as BSA, it does not enter the cell, and so can only be expressed at the cell membrane, activating newly identified specific signalling pathways. The University of Crete team treated mice, which had been given prostate cancer through inoculation with LNCaP cancer cells. They found that after one month of treatment with testosterone bound to the protein BSA (Bovine Serum Albumin) there was a 60% reduction in tumour size, with no apparent side-effects.
Professor Stournaras said:
This work strongly supports the concept that testosterone-protein conjugates, which activate membrane androgen receptors may represent a new class of experimental anti-tumour agents in prostate cancer. This is a new concept, and we need to make sure that these results can be transferred to humans in a satisfactory way. But if we can develop drugs that act safely on these Ambs (androgen membrane binding sites) then we may have a completely new therapeutic option for prostate cancer.
Jo Thurston | alfa
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
Layered 2D material improves efficiency for solar cells and LEDs
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...